What are the side effects of oral liraglutide for weight loss

Oral administration of liraglutide for weight loss may result in gastrointestinal reactions, hypoglycemia, pancreatitis, and other side effects. Lilalutide, as a GLP-1 receptor agonist, is mainly used for the treatment of type 2 diabetes. When it is used for weight loss, it should strictly follow the doctor's advice.

1. Gastrointestinal reactions

Nausea, vomiting, diarrhea, and abdominal distension are common adverse reactions. Delaying gastric emptying with liraglutide can stimulate the gastrointestinal mucosa, which may lead to decreased appetite and upper abdominal discomfort. Most patients experience symptoms during the initial stages of medication and gradually improve after 1-2 weeks. If the symptoms worsen or persist for more than 3 weeks, consider reducing or stopping the medication. Commonly used drugs in clinical practice include mosapride citrate tablets and loperamide hydrochloride capsules for symptomatic treatment.

2. The risk of hypoglycemia

is increased when combined with insulin or sulfonylurea drugs. Symptoms of sympathetic nervous system excitation include palpitations, sweating, dizziness, and fatigue. In severe cases, consciousness disorders may occur. It is recommended to regularly monitor fingertip blood sugar and carry glucose tablets with you. Diabetes patients should closely observe the changes of blood glucose when adjusting the hypoglycemic program.

3. Pancreatitis may occur.

Prolonged abdominal pain radiating to the back should alert to acute pancreatitis. Liraglutide may affect pancreatic enzyme secretion, leading to pancreatic duct obstruction. Blood tests showed a more than 3-fold increase in amylase levels, and imaging showed pancreatic edema. After diagnosis, medication should be stopped immediately and treated according to the standard for acute pancreatitis, such as injection of ustervastatin, octreotide acetate injection, etc.

4. Thyroid C-cell hyperplasia

Animal experiments have shown that it may increase the risk of medullary thyroid cancer. Before medication, thyroid nodules or family history should be checked, and calcitonin levels should be checked every 6 months during treatment. If a neck lump or hoarseness is found, ultrasound examination should be performed promptly.

5. Liver and kidney burden

Drugs may exacerbate organ dysfunction through liver and kidney metabolism. Patients with moderate to severe liver dysfunction need to adjust the dosage, and patients with creatinine clearance rate below 30ml/min are prohibited from using it. Regularly monitor transaminase and creatinine levels to avoid combination with other hepatotoxic drugs.

During the use of Liraglutide for weight loss, a balanced diet should be maintained, with a daily intake of no less than 1200 calories and 150 minutes of aerobic exercise per week. When serious side effects such as persistent vomiting, jaundice, or hematuria occur, stop taking the medication immediately and seek medical attention. Medication should be standardized under the guidance of an endocrinologist, avoiding self adjustment of dosage or extension of treatment course. During the medication period, alcohol consumption and high-fat diet are prohibited. It is recommended to check blood lipids, liver and kidney function indicators every 3 months.